Israeli Heart Surgeon World’s First To Receive 4th COVID-19 Vaccine

The Sheba Medical Center in Tel Hashomer, Israel’s largest hospital, has begun trials of a fourth dose of a COVID-19 vaccine, said to be the first study of its kind.

The trial began earlier this week with 150 medical staff who had received a booster dose in August. They received the fourth dose after testing and were found to have low antibody levels.

The trial came as Israeli officials considered launching a second tranche of booster injections to the population as the country grapples with rising Omicron-variant infections.

Professor Jacob Lavee, former director of Sheba’s heart transplant unit, was the first to participate in the trial. He said “hopefully we’ll be able to show here … that this fourth booster really does provide protection against the omicron, which is sorely needed.”

“This study will test the effect of the fourth dose of vaccine on the level of antibodies, in the prevention of contagion and will verify its safety”, said Professor Gili Regev-Yochay de Sheba, according to The Times of Israel.

“This study is expected to shed light on the additional benefit of giving a fourth dose and lead us to understand whether and to whom a fourth dose is worth giving,” he added.

Israel has been applauded for its swift launch of the vaccine campaign and was destined to become the first country in the world to launch a fourth dose for certain groups.

Leave a Comment